Further studies reported that in neural stem cells dopamine receptor D4 (DRD4) antagonists inhibit GBM growth, induce G0/G1 arrest and promote tumour cell differentiation and apoptosis in vitro [18]. Here, DRD4 is linked to glioblastoma.